No headlines found.
Diversified Healthcare Trust Announces Third Quarter 2025 Results
Business Wire (Mon, 3-Nov 4:15 PM ET)
Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares
Business Wire (Thu, 9-Oct 8:00 AM ET)
Business Wire (Wed, 8-Oct 8:00 AM ET)
Diversified Healthcare Trust Third Quarter 2025 Conference Call Scheduled for Tuesday, November 4th
Business Wire (Mon, 6-Oct 4:15 PM ET)
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.
Diversified Healthcare Trust - Common Shares Of Beneficial Interest trades on the NASDAQ stock market under the symbol DHC.
As of December 26, 2025, DHC stock price declined to $4.82 with 140,927 million shares trading.
DHC has a beta of 0.41, meaning it tends to be less sensitive to market movements. DHC has a correlation of 0.02 to the broad based SPY ETF.
DHC has a market cap of $1.17 billion. This is considered a Small Cap stock.
Last quarter Diversified Healthcare Trust - Common Shares Of Beneficial Interest reported $389 million in Revenue and $.04 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.15.
In the last 3 years, DHC traded as high as $5.16 and as low as $.62.
The top ETF exchange traded funds that DHC belongs to (by Net Assets): VNQ, VTI, IWM, FNDA, VXF.
DHC has outperformed the market in the last year with a return of +119.9%, while the SPY ETF gained +16.0%. In the last 3 month period, DHC beat the market returning +9.3%, while SPY returned +4.7%. However, in the most recent 2 weeks DHC has underperformed the stock market by returning -2.4%, while SPY returned +0.7%.
DHC support price is $4.77 and resistance is $5.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DHC shares will trade within this expected range on the day.